CHICAGO (Reuters) - A human protein generated while the body encounters environmental stress helped delay symptoms of amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease in mice, U.S.

New research from the University of St Andrews, the University of Copenhagen and Drexel University has developed AI ...

With a few shots of the protein that normally ails them, mouse models of amyotrophic lateral sclerosis stay healthy longer and gain an extra month of life once they do sicken, according to a paper in ...

Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in patients with amyotrophic lateral sclerosis. Now, a new study has not only ...

Pathological abnormalities associated with amyotrophic lateral sclerosis (ALS) have been identified in a mouse model using a new imaging technique developed at the University of Birmingham. Using the ...

Boston, MA and Providence, RI, July 07, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for ...

University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein ...

University of Florida Health researchers have developed a unique mouse model that will allow researchers around the world to better study the genetic origins and potential treatments for a ...

New research has discovered that reducing levels of the STAUFEN-1 protein can prevent neuron death caused by DNA damage and ...

Scientists at Mayo Clinic, Jacksonville, Florida created a novel mouse that exhibits the symptoms and neurodegeneration associated with the most common genetic forms of frontotemporal dementia (FTD) ...

Researchers have developed a gene therapy that significantly slowed motor function loss in preclinical models of amyotrophic lateral sclerosis (ALS), offering new hope for treating the devastating ...